BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35964818)

  • 1. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of Retinoblastoma.
    Mallipatna A; Marino M; Singh AD
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The
    Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
    Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
    [No Abstract]   [Full Text] [Related]  

  • 7. RB1: a prototype tumor suppressor and an enigma.
    Dyson NJ
    Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB1 gene mutations and genetic spectrum in retinoblastoma cases.
    Akdeniz Odemis D; Kebudi R; Bayramova J; Kilic Erciyas S; Kuru Turkcan G; Tuncer SB; Sukruoglu Erdogan O; Celik B; Kurt Gultaslar B; Buyukkapu Bay S; Tuncer S; Yazici H
    Medicine (Baltimore); 2023 Sep; 102(36):e35068. PubMed ID: 37682130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
    Indovina P; Pentimalli F; Conti D; Giordano A
    Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
    Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RB1 5́UTR contains an IRES related to cell cycle control and cancer progression.
    Ma W; Ma B; Ma J; Zhu R
    Gene; 2023 Dec; 887():147724. PubMed ID: 37604323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Same Mutation, Earlier Detection.
    Yaghy A; Eiger-Moscovich M; Shields CL
    Ophthalmol Retina; 2020 Apr; 4(4):402. PubMed ID: 32273112
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
    Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
    Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
    Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
    Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.